Nebenwirkungen · Januvia
Januvia 25 mg film-coated tablets Januvia 50 mg film-coated tablets Januvia 100 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-117248 · Präparat HOS-094553
Some adverse reactions were observed more frequently in studies of combination use of sitagliptin with other anti-diabetic medicinal products than in studies of sitagliptin monotherapy. These included hypoglycaemia (frequency very common with the combination of sulphonylurea and metformin), influenza (common with insulin (with or without metformin)), nausea and vomiting (common with metformin), flatulence (common with metformin or pioglitazone), constipation (common with the combination of sulphonylurea and metformin), peripheral oedema (common with pioglitazone or the combination of pioglitazone and metformin), somnolence and diarrhoea (uncommon with metformin), and dry mouth (uncommon with insulin (with or without metformin)).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-31T16:35:00Z · SHA-256 684e79d7f33051f725c708828e69a058036bdb187bd94aedb78e22b6c6654103 · Passage 077d93087739d084b152349b7ef2f94434d56b28b6729177f9fd04392dc27025 · Zeichen 4544–5282 im Abschnitt